Regulatory toxicology perspectives on the development of botanical drug products in the United States.

American journal of therapeutics

Volumn 11, Issue 3, 2004, Pages 213-217

  Wu, Kuei Meng ^a   Farrelly, James ^a   Birnkrant, Debra ^a   Chen, Shaw ^a   Dou, Jinhui ^a   Atrakchi, Aisar ^a   Bigger, Anita ^a   Chen, Conrad ^a   Chen, Zhou ^a   Freed, Lois ^a   Ghantous, Hanan ^a   Goheer, Anwar ^a   Hausner, Elizabeth ^a   Osterberg, Robert ^a   Rhee, Herman ^a   Zhang, K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PLANT MEDICINAL PRODUCT;

ANIMAL; CARCINOGEN TESTING; CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; MUTAGEN TESTING; REVIEW; TOXICOLOGY; UNITED STATES;

ANIMALS; CARCINOGENICITY TESTS; CLINICAL TRIALS; DRUGS, INVESTIGATIONAL; HUMANS; MUTAGENICITY TESTS; PLANT PREPARATIONS; TOXICOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 3843133110     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200405000-00010     Document Type: Review

References (18)